WHO Model List
pyrazinamide
International nonproprietary name (English: pyrazinamide). Brand names vary by country.
Indications retained by WHO
Tuberculosis.
Listed forms and strengths
- Oral > Solid > dispersible tablet: 150 mg
- Oral > Solid > tablet: 400 mg; 500 mg
Forms retained in the model list; presentations available in each country may differ.
General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.
Source: WHO electronic Essential Medicines List (2025 edition), checked on 14/11/2026. An error or an imprecision? Let us know
